LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Education
• Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

omt, cell, proliferation, cells, group, apoptosis, hemecs, treatment, pubmed, article, expression, migration, pten, hemangioma, catalog, effect, google, scholar, cycle, cancer, inhibition, fig, inhibitor, signaling, results, cas, analysis, endothelial, combined, invasion, central, significantly, control, effects, pathway, assay, showed, flow, inhibitors, data, liu, tumor, pathways, usa, oxymatrine, progression, vegfvegfr, proteins, phase, peng,

Topics {✒️}

akt/nf-κb signaling pathways article download pdf annexin v-fitc labeling pten/pi3k/akt signaling axis vegfa/vegfr-2 autocrine loop hrp-labeled secondary antibody vegf/vegfr autocrine loop phosphoinositide 3-kinase/protein kinase akt/raf-1-dependent pathway inactivates pi3k/akt signaling pi3k/akt signaling pathway irradiation-induced hematopoietic injury pten tumour suppressor writing—original draft preparation vegfa/vegfr-2 signaling pathway cold serum-free medium annexin v-fitc pten/pi3k/akt pathway infantile hemangioma originates vegf/vegfr axis revisited modulating mapk/erk phosphorylation hemangioma-derived endothelial cells vegf/vegfr signaling pathway related subjects including pten/pi3k/akt /pi double labeling reverse transcription pcr infantile hemangiomas pi3k/akt pathway [13] pi3k/akt pathway [17 pi3k/akt pathway privacy choices/manage cookies autocrine growth factor apoptosis-related proteins bcl-2 play vital roles additional information publisher' key proteins related full access nat rev cancer references thomann inhibiting mir-93-5p context-dependent nature biol pharm bull article peng pten/pi3k/akt mir-494 promotes progression pro-apoptotic proteins bax original author signal transduction pathways autocrine loop

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Inhibition of hemangioma development by regulating the VEGF/VEGFR autocrine loop via the miR-494/PTEN pathway
         description:Infantile hemangioma (IH) is the most common type of benign vascular tumor found in infants and young children. Hemangioma-derived endothelial cells within the lesion from birth to three months of age are the primary characteristic of IH. (hemangioma-derived endothelial cells, HemECs) proliferated rapidly and formed hemangioma masses, most of which gradually regressed spontaneously within the next 1 to 5 years of age and continued to improve until the age of 6 to 12 years. But 10–15% of IH cases can still result in ulcerative, obstructive, deformity, and even potentially fatal consequences and sequelae. These conditions seriously affect children's physical and mental health as well as their growth and development, necessitating prompt and efficient medical attention of IH is known. The purpose of this work. HemECs are crucial to the development of IH as a result. Not all of the pathophwork is to examine the impact of OMT on HemECs, with a specific emphasis on its role in cell migration, proliferation, cell cycle regulation, and apoptosis. Additionally, we will research the influence of OMT on the VEGFA/VEGFR-2 signaling pathway in HemECs and assess the impact of OMT on the miR-494/PTEN axis. The Cell Counting Kit-8 (CCK-8) assay was employed to evaluate the influence of Oxymatrine (OMT) on the proliferation of Hemangioma Endothelial Cells (HemECs). The Transwell Assay was employed to detect cell invasion and migration. The cell cycle and apoptosis were analyzed through flow cytometry. The impact of OMT on the expression of apoptosis markers (cleaved caspase-3) and proteins associated with the cell cycle (Cyclin D1, Bcl-2, Bax) was examined using Western Blot and Reverse Transcription Polymerase Chain Reaction (RT-PCR). OMT treatment significantly inhibited the proliferation of HemECs, especially when combined with the miR-494 inhibitor. Additionally, OMT administration raised the proportion of cells entering the G2 phase, accelerated apoptosis, and decreased HemECs' capacity for migration and invasion. The results of Western Blot and RT-PCR demonstrated that OMT decreased the expression levels of Bax and Cleaved Caspase-3 while increasing the expression of Bcl-2 and Cyclin D1. OMT and miR-494 inhibitors have distinct impacts on the phosphorylated versions of VEGFR-2, PTEN, and ERK signaling pathways. OMT may control cell survival and proliferation through the miR-494/PTEN pathway, as evidenced by the fact that PTEN expression was dramatically upregulated in the miR-1297 inhibitor with OMT treatment group, while p-ERK expression was markedly reduced in that group. OMT effectively inhibits the growth, migration, and apoptosis of hemangioma endothelial cells, likely by regulating key proteins involved in the cell cycle and apoptosis. The combination with miR-494 inhibitors enhances its therapeutic effect, suggesting a potential new approach for hemangioma treatment. These findings support the development of OMT-based strategies for hemangiomas and its potential use in cancer therapy.
         datePublished:2025-02-12T00:00:00Z
         dateModified:2025-02-12T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1007/s12672-025-01802-1
         keywords:
            Oxymatrine
            miR-494
            VEGFVEGFR autocrine loop
            Hemangioma
            Oncology
            Cancer Research
            Surgical Oncology
            Molecular Medicine
            Radiotherapy
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig7_HTML.png
         isPartOf:
            name:Discover Oncology
            issn:
               2730-6011
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jingyu Peng
               affiliation:
                     name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                     address:
                        name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feifei Li
               affiliation:
                     name:Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences
                     address:
                        name:Department of Health Vascular Surgery and Intervention, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mingke Qiu
               affiliation:
                     name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                     address:
                        name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinjie Xu
               affiliation:
                     name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                     address:
                        name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guanghua Liu
               affiliation:
                     name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                     address:
                        name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jingmin Ou
               affiliation:
                     name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                     address:
                        name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inhibition of hemangioma development by regulating the VEGF/VEGFR autocrine loop via the miR-494/PTEN pathway
      description:Infantile hemangioma (IH) is the most common type of benign vascular tumor found in infants and young children. Hemangioma-derived endothelial cells within the lesion from birth to three months of age are the primary characteristic of IH. (hemangioma-derived endothelial cells, HemECs) proliferated rapidly and formed hemangioma masses, most of which gradually regressed spontaneously within the next 1 to 5 years of age and continued to improve until the age of 6 to 12 years. But 10–15% of IH cases can still result in ulcerative, obstructive, deformity, and even potentially fatal consequences and sequelae. These conditions seriously affect children's physical and mental health as well as their growth and development, necessitating prompt and efficient medical attention of IH is known. The purpose of this work. HemECs are crucial to the development of IH as a result. Not all of the pathophwork is to examine the impact of OMT on HemECs, with a specific emphasis on its role in cell migration, proliferation, cell cycle regulation, and apoptosis. Additionally, we will research the influence of OMT on the VEGFA/VEGFR-2 signaling pathway in HemECs and assess the impact of OMT on the miR-494/PTEN axis. The Cell Counting Kit-8 (CCK-8) assay was employed to evaluate the influence of Oxymatrine (OMT) on the proliferation of Hemangioma Endothelial Cells (HemECs). The Transwell Assay was employed to detect cell invasion and migration. The cell cycle and apoptosis were analyzed through flow cytometry. The impact of OMT on the expression of apoptosis markers (cleaved caspase-3) and proteins associated with the cell cycle (Cyclin D1, Bcl-2, Bax) was examined using Western Blot and Reverse Transcription Polymerase Chain Reaction (RT-PCR). OMT treatment significantly inhibited the proliferation of HemECs, especially when combined with the miR-494 inhibitor. Additionally, OMT administration raised the proportion of cells entering the G2 phase, accelerated apoptosis, and decreased HemECs' capacity for migration and invasion. The results of Western Blot and RT-PCR demonstrated that OMT decreased the expression levels of Bax and Cleaved Caspase-3 while increasing the expression of Bcl-2 and Cyclin D1. OMT and miR-494 inhibitors have distinct impacts on the phosphorylated versions of VEGFR-2, PTEN, and ERK signaling pathways. OMT may control cell survival and proliferation through the miR-494/PTEN pathway, as evidenced by the fact that PTEN expression was dramatically upregulated in the miR-1297 inhibitor with OMT treatment group, while p-ERK expression was markedly reduced in that group. OMT effectively inhibits the growth, migration, and apoptosis of hemangioma endothelial cells, likely by regulating key proteins involved in the cell cycle and apoptosis. The combination with miR-494 inhibitors enhances its therapeutic effect, suggesting a potential new approach for hemangioma treatment. These findings support the development of OMT-based strategies for hemangiomas and its potential use in cancer therapy.
      datePublished:2025-02-12T00:00:00Z
      dateModified:2025-02-12T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1007/s12672-025-01802-1
      keywords:
         Oxymatrine
         miR-494
         VEGFVEGFR autocrine loop
         Hemangioma
         Oncology
         Cancer Research
         Surgical Oncology
         Molecular Medicine
         Radiotherapy
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-01802-1/MediaObjects/12672_2025_1802_Fig7_HTML.png
      isPartOf:
         name:Discover Oncology
         issn:
            2730-6011
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jingyu Peng
            affiliation:
                  name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                  address:
                     name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feifei Li
            affiliation:
                  name:Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences
                  address:
                     name:Department of Health Vascular Surgery and Intervention, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mingke Qiu
            affiliation:
                  name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                  address:
                     name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinjie Xu
            affiliation:
                  name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                  address:
                     name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guanghua Liu
            affiliation:
                  name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                  address:
                     name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jingmin Ou
            affiliation:
                  name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
                  address:
                     name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Discover Oncology
      issn:
         2730-6011
      volumeNumber:16
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
      address:
         name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
         type:PostalAddress
      name:Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences
      address:
         name:Department of Health Vascular Surgery and Intervention, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China
         type:PostalAddress
      name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
      address:
         name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
         type:PostalAddress
      name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
      address:
         name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
         type:PostalAddress
      name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
      address:
         name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
         type:PostalAddress
      name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
      address:
         name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jingyu Peng
      affiliation:
            name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
            address:
               name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Feifei Li
      affiliation:
            name:Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences
            address:
               name:Department of Health Vascular Surgery and Intervention, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Mingke Qiu
      affiliation:
            name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
            address:
               name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xinjie Xu
      affiliation:
            name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
            address:
               name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Guanghua Liu
      affiliation:
            name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
            address:
               name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Jingmin Ou
      affiliation:
            name:XinHua Hospital, Shanghai Jiaotong University School of Medcine
            address:
               name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
      name:Department of Health Vascular Surgery and Intervention, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China
      name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
      name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
      name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China
      name:Department of Intervention and Vascular Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medcine, Shanghai, China

External Links {🔗}(137)

• See how much https://www.springernature.com/gp/authors makes per month
• What is the monthly revenue of https://link.springernature.com/home/?
• How much profit is https://order.springer.com/public/cart making per month?
• What are the earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• How much revenue does https://submission.nature.com/new-submission/12672/3 produce monthly?
• How much income does https://beta.springernature.com/pre-submission?journalId=12672 have?
• How much does https://figshare.com/s/5350c767cff818cd06bf generate monthly?
• How much profit does https://doi.org/10.1369%2F00221554221112701 make?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35815421
• What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284234?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Digital%20staging%20of%20hepatic%20hemangiomas%20reveals%20spatial%20heterogeneity%20in%20endothelial%20cell%20composition%20and%20vascular%20senescence&journal=J%20Histochem%20Cytochem&doi=10.1369%2F00221554221112701&volume=70&issue=7&pages=531-541&publication_year=2022&author=Thomann%2CS&author=T%C3%B3th%2CM&author=Sprengel%2CSD&author=Liermann%2CJ&author=Schirmacher%2CP make?
• Revenue of https://doi.org/10.1684%2Fejd.2023.4484
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37594334
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Propranolol%20for%20the%20treatment%20of%20infantile%20hemangiomas%3A%20a%20nine-year%20monocentric%20experience%20from%20a%20tertiary%20hospital&journal=Eur%20J%20Dermatol&doi=10.1684%2Fejd.2023.4484&volume=33&issue=3&pages=265-269&publication_year=2023&author=Volont%C3%A9%2CM&author=Codazzi%2CAC&author=Davidovich%2CS&author=Apicella%2CA&author=Isoletta%2CE&author=Barruscotti%2CS&author=Massa%2CM&author=Silvestri%2CA&author=Marseglia%2CGL&author=Brazzelli%2CV?
• https://doi.org/10.1016%2Fj.yexcr.2023.113603 income
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37075826's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=Oxymatrine%20boosts%20hematopoietic%20regeneration%20by%20modulating%20MAPK%2FERK%20phosphorylation%20after%20irradiation-induced%20hematopoietic%20injury&journal=Exp%20Cell%20Res&doi=10.1016%2Fj.yexcr.2023.113603&volume=427&issue=2&publication_year=2023&author=Yang%2CL&author=Lu%2CY&author=Zhang%2CZ&author=Chen%2CY&author=Chen%2CN&author=Chen%2CF&author=Qi%2CY&author=Han%2CC&author=Xu%2CY&author=Chen%2CM&author=Shen%2CM&author=Wang%2CS&author=Zeng%2CH&author=Su%2CY&author=Hu%2CM&author=Wang%2CJ pull in monthly?
• What's the income of https://doi.org/10.1248%2Fbpb.b17-00010?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28769005?
• How much does http://scholar.google.com/scholar_lookup?&title=Oxymatrine%20promotes%20S-phase%20arrest%20and%20inhibits%20cell%20proliferation%20of%20human%20breast%20cancer%20cells%20in%20vitro%20through%20mitochondria-mediated%20apoptosis&journal=Biol%20Pharm%20Bull&doi=10.1248%2Fbpb.b17-00010&volume=40&issue=8&pages=1232-1239&publication_year=2017&author=Wu%2CJ&author=Cai%2CY&author=Li%2CM&author=Zhang%2CY&author=Li%2CH&author=Tan%2CZ rake in every month?
• What's the income generated by https://doi.org/10.1002%2Fjcb.29469 each month?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31736157?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Matrine%20involves%20in%20the%20progression%20of%20gastric%20cancer%20through%20inhibiting%20miR-93-5p%20and%20upregulating%20the%20expression%20of%20target%20gene%20AHNAK&journal=J%20Cell%20Biochem&doi=10.1002%2Fjcb.29469&volume=121&issue=3&pages=2467-2477&publication_year=2020&author=Liu%2CZM&author=Yang%2CXL&author=Jiang%2CF&author=Pan%2CYC&author=Zhang%2CL?
• https://doi.org/10.1016%2Fj.tig.2023.01.009's financial summary
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36863945?
• Revenue of http://scholar.google.com/scholar_lookup?&title=miRNA%20biogenesis%20and%20inherited%20disorders%3A%20clinico-molecular%20insights&journal=Trends%20Genet&doi=10.1016%2Fj.tig.2023.01.009&volume=39&issue=5&pages=401-414&publication_year=2023&author=Pelletier%2CD&author=Rivera%2CB&author=Fabian%2CMR&author=Foulkes%2CWD
• How much does https://doi.org/10.1016%2Fj.molcel.2020.02.020 earn?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32191872 pull in?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201373 net monthly?
• http://scholar.google.com/scholar_lookup?&title=Ago2-dependent%20processing%20allows%20miR-451%20to%20evade%20the%20global%20microRNA%20turnover%20elicited%20during%20erythropoiesis&journal=Mol%20Cell&doi=10.1016%2Fj.molcel.2020.02.020&volume=78&issue=2&pages=317-328.e6&publication_year=2020&author=Kretov%2CDA&author=Walawalkar%2CIA&author=Mora-Martin%2CA&author=Shafik%2CAM&author=Moxon%2CS&author=Cifuentes%2CD's total income per month
• How much income is https://doi.org/10.1111%2Fcas.13177 earning monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28132399 bring in each month?
• How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406601 make?
• http://scholar.google.com/scholar_lookup?&title=MicroRNA-155-5p%20promotes%20hepatocellular%20carcinoma%20progression%20by%20suppressing%20PTEN%20through%20the%20PI3K%2FAkt%20pathway&journal=Cancer%20Sci&doi=10.1111%2Fcas.13177&volume=108&issue=4&pages=620-631&publication_year=2017&author=Fu%2CX&author=Wen%2CH&author=Jing%2CL&author=Yang%2CY&author=Wang%2CW&author=Liang%2CX&author=Nan%2CK&author=Yao%2CY&author=Tian%2CT's financial summary
• Earnings of https://doi.org/10.3389%2Ffcell.2021.671461
• Income figures for http://scholar.google.com/scholar_lookup?&title=MicroRNA-494%20regulates%20endoplasmic%20reticulum%20stress%20in%20endothelial%20cells&journal=Front%20Cell%20Dev%20Biol&doi=10.3389%2Ffcell.2021.671461&volume=12&issue=9&publication_year=2021&author=Chatterjee%2CN&author=Fraile-Bethencourt%2CE&author=Baris%2CA&author=Espinosa-Diez%2CC&author=Anand%2CS
• Earnings of https://doi.org/10.1038/s41580-018-0015-0
• How much revenue does https://doi.org/10.1038%2Fs41580-018-0015-0 bring in?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29858604
• http://scholar.google.com/scholar_lookup?&title=The%20functions%20and%20regulation%20of%20the%20PTEN%20tumour%20suppressor%3A%20new%20modes%20and%20prospects&journal=Nat%20Rev%20Mol%20Cell%20Biol&doi=10.1038%2Fs41580-018-0015-0&volume=19&issue=9&pages=547-562&publication_year=2018&author=Lee%2CY-R&author=Chen%2CM&author=Pandolfi%2CPP's financial summary
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=PTEN%20regulation%20of%20signal%20transduction%20pathways%20in%20cancer%3A%20AKTing%20out%2C%20double%20negatives%2C%20and%20more&journal=Nat%20Rev%20Cancer&volume=18&issue=9&pages=614-630&publication_year=2018&author=Hopkins%2CBD&author=Goncalves%2CMD
• What are the earnings of https://doi.org/10.1101%2Fcshperspect.a036095?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31932468
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328454
• http://scholar.google.com/scholar_lookup?&title=Posttranslational%20regulation%20and%20conformational%20plasticity%20of%20PTEN&journal=Cold%20Spring%20Harb%20Perspect%20Med&doi=10.1101%2Fcshperspect.a036095&volume=10&issue=7&publication_year=2020&author=Kotelevets%2CL&author=Trifault%2CB&author=Chastre%2CE&author=Scott%2CMGH's revenue stream
• Explore the financials of https://doi.org/10.3390%2Fcancers13030514
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33572780 net monthly?
• How much income is http://scholar.google.com/scholar_lookup?&title=MicroRNAs%20in%20the%20pathogenesis%20of%20hepatocellular%20carcinoma%3A%20a%20review&journal=Cancers%20%28Basel%29&doi=10.3390%2Fcancers13030514&volume=13&issue=3&publication_year=2021&author=Morishita%2CA&author=Oura%2CK&author=Tadokoro%2CT&author=Fujita%2CK&author=Tani%2CJ&author=Masaki%2CT earning monthly?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26040900
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Tumor-derived%20microRNA-494%20promotes%20angiogenesis%20in%20non-small%20cell%20lung%20cancer&journal=Angiogenesis&doi=10.1007%2Fs10456-015-9474-5&volume=18&issue=3&pages=373-382&publication_year=2015&author=Mao%2CG&author=Liu%2CY&author=Fang%2CX&author=Liu%2CY&author=Fang%2CL&author=Lin%2CL&author=Liu%2CX&author=Wang%2CN?
• How much does http://scholar.google.com/scholar_lookup?&title=miR-494%20protects%20pancreatic%20%CE%B2-cell%20function%20by%20targeting%20PTEN%20in%20gestational%20diabetes%20mellitus&journal=EXCLI%20J&volume=12&issue=16&pages=1297-1307&publication_year=2017&author=He%2CY&author=Bai%2CJ&author=Liu%2CP&author=Dong%2CJ&author=Tang%2CY&author=Zhou%2CJ&author=Han%2CP&author=Xing%2CJ&author=Chen%2CY&author=Yu%2CX gross monthly?
• Find out how much https://doi.org/10.1038%2Fs41598-018-28519-2 earns monthly
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29992971
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041272 income
• Find out how much http://scholar.google.com/scholar_lookup?&title=MiR-494-3p%20promotes%20PI3K%2FAKT%20pathway%20hyperactivation%20and%20human%20hepatocellular%20carcinoma%20progression%20by%20targeting%20PTEN&journal=Sci%20Rep&doi=10.1038%2Fs41598-018-28519-2&volume=8&issue=1&publication_year=2018&author=Lin%2CH&author=Huang%2CZP&author=Liu%2CJ&author=Qiu%2CY&author=Tao%2CYP&author=Wang%2CMC&author=Yao%2CH&author=Hou%2CKZ&author=Gu%2CFM&author=Xu%2CXF earns monthly
• What are the total earnings of https://doi.org/10.1038%2Fs41598-019-39453-2?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30816202 is on a monthly basis
• What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395740's gross income?
• See how much http://scholar.google.com/scholar_lookup?&title=MiR-494%20acts%20as%20a%20tumor%20promoter%20by%20targeting%20CASP2%20in%20non-small%20cell%20lung%20cancer&journal=Sci%20Rep&doi=10.1038%2Fs41598-019-39453-2&volume=9&issue=1&publication_year=2019&author=Zhang%2CQ&author=Li%2CY&author=Zhao%2CM&author=Lin%2CH&author=Wang%2CW&author=Li%2CD&author=Cui%2CW&author=Zhou%2CC&author=Zhong%2CJ&author=Huang%2CC makes per month
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=38074823
• How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10703645 have?
• Profit of http://scholar.google.com/scholar_lookup?&title=Role%20of%20microRNA-494%20in%20tumor%20progression&journal=Am%20J%20Transl%20Res&volume=15&issue=11&pages=6342-6361&publication_year=2023&author=Maharati%2CA&author=Akhlaghipour%2CI&author=Taghehchian%2CN&author=Farshchian%20Yazdi%2CZ&author=Moghbeli%2CM
• What's the financial outcome of https://doi.org/10.3390%2Fijms232415585?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36555234 generate?
• What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779738?
• Income figures for http://scholar.google.com/scholar_lookup?&title=The%20VEGF%2FVEGFR%20axis%20revisited%3A%20implications%20for%20cancer%20therapy&journal=Int%20J%20Mol%20Sci&doi=10.3390%2Fijms232415585&volume=23&issue=24&publication_year=2022&author=Mabeta%2CP&author=Steenkamp%2CV
• How much does https://doi.org/10.1158%2F1078-0432.CCR-22-1366 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35969170 generate monthly?
• Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274152's earnings
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Molecular%20mechanisms%20and%20future%20implications%20of%20VEGF%2FVEGFR%20in%20cancer%20therapy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-22-1366&volume=29&issue=1&pages=30-39&publication_year=2023&author=Patel%2CSA&author=Nilsson%2CMB&author=Le%2CX&author=Cascone%2CT&author=Jain%2CRK&author=Heymach%2CJV
• How much does http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20is%20an%20autocrine%20growth%20factor%2C%20signaling%20through%20neuropilin-1%20in%20non-small%20cell%20lung%20cancer&journal=Mol%20Cancer&doi=10.1186%2Fs12943-015-0310-8&volume=20&issue=14&publication_year=2015&author=Barr%2CMP&author=Gray%2CSG&author=Gately%2CK&author=Hams%2CE&author=Fallon%2CPG&author=Davies%2CAM&author=Richard%2CDJ&author=Pidgeon%2CGP&author=O%27Byrne%2CKJ rake in every month?
• How much money does https://doi.org/10.1038%2Fs41467-020-17525-6 generate?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32709869 earn?
• Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382445
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20paradigm%20of%20dual%20targeting%20VEGF%20and%20PDGF%20for%20effectively%20treating%20FGF-2%20off-target%20tumors&journal=Nat%20Commun&doi=10.1038%2Fs41467-020-17525-6&volume=11&issue=1&publication_year=2020&author=Hosaka%2CK&author=Yang%2CY&author=Seki%2CT&author=Du%2CQ&author=Jing%2CX&author=He%2CX&author=Wu%2CJ&author=Zhang%2CY&author=Morikawa%2CH&author=Nakamura%2CM&author=Scherzer%2CM&author=Sun%2CX&author=Xu%2CY&author=Cheng%2CT&author=Li%2CX&author=Liu%2CX&author=Li%2CQ&author=Liu%2CY&author=Hong%2CA&author=Chen%2CY&author=Cao%2CY?
• https://doi.org/10.3892%2Fol.2020.11749's financial summary
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32724440 pull in?
• How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377044 have monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=miR-494%20promotes%20progression%20of%20retinoblastoma%20via%20PTEN%20through%20PI3K%2FAKT%20signaling%20pathway&journal=Oncol%20Lett&doi=10.3892%2Fol.2020.11749&volume=20&issue=2&pages=1952-1960&publication_year=2020&author=Xu%2CF&author=Liu%2CG&author=Wang%2CL&author=Wang%2CX&author=Jin%2CX&author=Bo%2CW gross monthly?
• How much does https://doi.org/10.1172%2FJCI65385 make?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23454747
• Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613914
• http://scholar.google.com/scholar_lookup?&title=Tumor%20VEGF%3A%20VEGFR2%20autocrine%20feed-forward%20loop%20triggers%20angiogenesis%20in%20lung%20cancer&journal=J%20Clin%20Invest&doi=10.1172%2FJCI65385&volume=123&issue=4&pages=1732-1740&publication_year=2013&author=Chatterjee%2CS&author=Heukamp%2CLC&author=Siobal%2CM&author=Sch%C3%B6ttle%2CJ&author=Wieczorek%2CC&author=Peifer%2CM&author=Frasca%2CD&author=Koker%2CM&author=K%C3%B6nig%2CK&author=Meder%2CL&author=Rauh%2CD&author=Buettner%2CR&author=Wolf%2CJ&author=Brekken%2CRA&author=Neumaier%2CB&author=Christofori%2CG&author=Thomas%2CRK&author=Ullrich%2CRT income
• How much income is https://doi.org/10.1016%2Fj.phrs.2019.104327 earning monthly?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31283981
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Anti-cancer%20effects%20of%20oxymatrine%20are%20mediated%20through%20multiple%20molecular%20mechanism%28s%29%20in%20tumor%20models&journal=Pharmacol%20Res&doi=10.1016%2Fj.phrs.2019.104327&volume=147&publication_year=2019&author=Halim%2CCE&author=Xinjing%2CSL&author=Fan%2CL&author=Bailey%20Vitarbo%2CJ&author=Arfuso%2CF&author=Tan%2CCH&author=Narula%2CAS&author=Kumar%2CAP&author=Sethi%2CG&author=Ahn%2CKS?
• https://doi.org/10.1038%2Fs41392-021-00728-8's revenue stream
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34462428 generate?
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405630
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Ribosomal%20proteins%20and%20human%20diseases%3A%20molecular%20mechanisms%20and%20targeted%20therapy&journal=Signal%20Transduct%20Target%20Ther&doi=10.1038%2Fs41392-021-00728-8&volume=6&issue=1&publication_year=2021&author=Kang%2CJ&author=Brajanovski%2CN&author=Chan%2CKT&author=Xuan%2CJ&author=Pearson%2CRB&author=Sanij%2CE?
• Explore the financials of https://doi.org/10.3390%2Fijms20030656
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30717416?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386883?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Molecular%20mechanisms%20of%20action%20of%20tocotrienols%20in%20cancer%3A%20recent%20trends%20and%20advancements&journal=Int%20J%20Mol%20Sci&doi=10.3390%2Fijms20030656&volume=20&issue=3&publication_year=2019&author=Aggarwal%2CV&author=Kashyap%2CD&author=Sak%2CK&author=Tuli%2CHS&author=Jain%2CA&author=Chaudhary%2CA&author=Garg%2CVK&author=Sethi%2CG&author=Yerer%2CMB?
• What are the total earnings of https://doi.org/10.1038%2Fs41420-023-01405-1?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37117198?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147665?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Dual%20role%20of%20PID1%20in%20regulating%20apoptosis%20induced%20by%20distinct%20anticancer-agents%20through%20AKT%2FRaf-1-dependent%20pathway%20in%20hepatocellular%20carcinoma&journal=Cell%20Death%20Discov&doi=10.1038%2Fs41420-023-01405-1&volume=9&issue=1&publication_year=2023&author=Yang%2CJ&author=Li%2CS&author=He%2CJ&author=Xu%2CQ&author=Xie%2CM&author=Yang%2CC&author=Wang%2CH&author=Zhang%2CY&author=Wan%2CQ&author=Xiang%2CM
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29304823
• Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755155
• How much profit is http://scholar.google.com/scholar_lookup?&title=MicroRNA-494%20promotes%20cancer%20progression%20and%20targets%20adenomatous%20polyposis%20coli%20in%20colorectal%20cancer&journal=Mol%20Cancer&doi=10.1186%2Fs12943-017-0753-1&volume=17&issue=1&publication_year=2018&author=Zhang%2CY&author=Guo%2CL&author=Li%2CY&author=Feng%2CGH&author=Teng%2CF&author=Li%2CW&author=Zhou%2CQ making per month?
• How much does https://doi.org/10.3892%2Fol.2020.12021 net monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32934728 make?
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471709's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=MicroRNA-23b-3p%20promotes%20pancreatic%20cancer%20cell%20tumorigenesis%20and%20metastasis%20via%20the%20JAK%2FPI3K%20and%20Akt%2FNF-%CE%BAB%20signaling%20pathways&journal=Oncol%20Lett&doi=10.3892%2Fol.2020.12021&volume=20&issue=5&publication_year=2020&author=Zhang%2CY&author=Chen%2CD&author=Zhang%2CG&author=Wu%2CX&author=Zhou%2CL&author=Lin%2CY&author=Ding%2CJ&author=An%2CF&author=Zhan%2CQ make?
• How much profit does https://citation-needed.springer.com/v2/references/10.1007/s12672-025-01802-1?format=refman&flavour=references make?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jingyu%20Peng pull in monthly?
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jingyu%20Peng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feifei%20Li?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feifei%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mingke%20Qiu?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mingke%20Qiu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xinjie%20Xu's earnings
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xinjie%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guanghua%20Liu
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guanghua%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jingmin%20Ou gross monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jingmin%20Ou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• How much does http://creativecommons.org/licenses/by-nc-nd/4.0/ net monthly?
• How much income is https://s100.copyright.com/AppDispatchServlet?title=Inhibition%20of%20hemangioma%20development%20by%20regulating%20the%20VEGF%2FVEGFR%20autocrine%20loop%20via%20the%20miR-494%2FPTEN%20pathway&author=Jingyu%20Peng%20et%20al&contentID=10.1007%2Fs12672-025-01802-1©right=The%20Author%28s%29&publication=2730-6011&publicationDate=2025-02-12&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-ND earning monthly?
• Discover the revenue of https://crossmark.crossref.org/dialog/?doi=10.1007/s12672-025-01802-1
• How much money does https://citation-needed.springer.com/v2/references/10.1007/s12672-025-01802-1?format=refman&flavour=citation generate?
• How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral generate monthly?
• Earnings of https://www.springernature.com/gp/products
• Profit of https://www.springernature.com/gp/librarians
• https://www.springernature.com/gp/societies income
• Earnings of https://www.springernature.com/gp/partners
• See how much https://www.springer.com/ makes per month
• What are the total earnings of https://www.nature.com/?
• How much profit does https://www.biomedcentral.com/ generate?
• Earnings of https://www.palgrave.com/
• https://www.apress.com/'s financial summary
• What are the total earnings of https://www.springernature.com/gp/legal/ccpa?
• What's the financial outcome of https://www.springernature.com/gp/info/accessibility?
• What is the monthly revenue of https://support.springernature.com/en/support/home?
• What's the financial intake of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• How much does https://www.springernature.com/ net monthly?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref